Tieton Capital Management, LLC Chroma Dex Corp. Transaction History

Tieton Capital Management, LLC

$193 Million
Q3 2024

A detailed history of Tieton Capital Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Tieton Capital Management, LLC holds 2,956,120 shares of CDXC stock, worth $16.2 Million. This represents 5.59% of its overall portfolio holdings.

Number of Shares

2,956,120

Previous 2,968,060 0.4%

Holding current value

$16.2 Million

Previous $8.1 Million 33.16%

% of portfolio

5.59%

Previous 4.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.51 - $3.8 $29,969 - $45,372	-11,940 Reduced 0.4%	2,956,120 $10.8 Million
Q2 2024 Aug 09, 2024	SELL	$2.44 - $4.32 $131,308 - $232,480	-53,815 Reduced 1.78%	2,968,060 $8.1 Million
Q1 2024 May 10, 2024	BUY	$1.36 - $3.84 $147,152 - $415,488	108,200 Added 3.71%	3,021,875 $10.5 Million
Q4 2023 Feb 09, 2024	BUY	$1.28 - $1.6 $590,965 - $738,707	461,692 Added 18.83%	2,913,675 $4.17 Million
Q3 2023 Nov 01, 2023	SELL	$1.36 - $1.77 $160,704 - $209,152	-118,165 Reduced 4.6%	2,451,983 $3.58 Million
Q2 2023 Aug 14, 2023	BUY	$1.31 - $1.79 $28,083 - $38,374	21,438 Added 0.84%	2,570,148 $4.04 Million
Q1 2023 May 10, 2023	SELL	$1.48 - $2.19 $290,544 - $429,927	-196,314 Reduced 7.15%	2,548,710 $3.9 Million
Q4 2022 Feb 10, 2023	BUY	$1.25 - $1.94 $586,786 - $910,692	469,429 Added 20.63%	2,745,024 $4.61 Million
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.06 $11,209 - $19,405	-9,420 Reduced 0.41%	2,275,595 $2.8 Million
Q2 2022 Aug 10, 2022	BUY	$1.59 - $2.7 $1.36 Million - $2.31 Million	856,273 Added 59.93%	2,285,015 $3.82 Million
Q1 2022 May 10, 2022	BUY	$2.02 - $3.92 $2.04 Million - $3.97 Million	1,012,016 Added 242.85%	1,428,742 $3.52 Million
Q4 2021 Feb 10, 2022	BUY	$3.74 - $6.7 $433,062 - $775,806	115,792 Added 38.48%	416,726 $1.56 Million
Q3 2021 Nov 10, 2021	SELL	$6.05 - $10.41 $53,451 - $91,972	-8,835 Reduced 2.85%	300,934 $1.89 Million
Q2 2021 Aug 10, 2021	SELL	$6.66 - $10.92 $7,092 - $11,629	-1,065 Reduced 0.34%	309,769 $3.05 Million
Q1 2021 May 10, 2021	SELL	$4.59 - $18.74 $3.87 Million - $15.8 Million	-842,270 Reduced 73.04%	310,834 $2.9 Million
Q4 2020 Feb 11, 2021	SELL	$3.93 - $5.5 $144,624 - $202,400	-36,800 Reduced 3.09%	1,153,104 $5.54 Million
Q3 2020 Nov 12, 2020	BUY	$4.01 - $5.56 $694,227 - $962,569	173,124 Added 17.03%	1,189,904 $4.77 Million
Q2 2020 Aug 12, 2020	SELL	$3.0 - $5.52 $1.35 Million - $2.48 Million	-448,762 Reduced 30.62%	1,016,780 $4.67 Million
Q1 2020 May 11, 2020	SELL	$2.54 - $4.75 $207,225 - $387,528	-81,585 Reduced 5.27%	1,465,542 $4.78 Million
Q4 2019 Feb 11, 2020	BUY	$2.83 - $4.61 $354,449 - $577,388	125,247 Added 8.81%	1,547,127 $6.67 Million
Q3 2019 Nov 12, 2019	BUY	$3.83 - $4.72 $380,357 - $468,743	99,310 Added 7.51%	1,421,880 $5.6 Million
Q2 2019 Aug 09, 2019	BUY	$3.71 - $4.83 $239,962 - $312,404	64,680 Added 5.14%	1,322,570 $6.15 Million
Q1 2019 May 10, 2019	BUY	$3.2 - $4.19 $529,360 - $693,130	165,425 Added 15.14%	1,257,890 $5.27 Million
Q4 2018 Feb 08, 2019	BUY	$2.8 - $4.22 $31,415 - $47,348	11,220 Added 1.04%	1,092,465 $3.75 Million
Q3 2018 Nov 09, 2018	BUY	$3.5 - $4.91 $603,379 - $846,454	172,394 Added 18.97%	1,081,245 $4.64 Million
Q2 2018 Aug 08, 2018	BUY	$3.22 - $4.43 $1.12 Million - $1.54 Million	348,131 Added 62.09%	908,851 $3.37 Million
Q1 2018 May 10, 2018	SELL	$4.05 - $6.46 $31,104 - $49,612	-7,680 Reduced 1.35%	560,720 $2.36 Million
Q4 2017 Feb 12, 2018	SELL	$3.88 - $6.96 $86,531 - $155,221	-22,302 Reduced 3.78%	568,400 $3.34 Million
Q3 2017 Nov 09, 2017	BUY	$2.91 - $4.71 $1.72 Million - $2.78 Million	590,702	590,702 $2.54 Million

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tieton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tieton Capital Management, LLC with notifications on news.

Account

Tieton Capital Management, LLC Chroma Dex Corp. Transaction History